StreetInsider.com News Articles

Bruker Announces Quarterly Preferred Stock Dividend

Thu, 05 Feb 2026 16:05:00 -0500

BILLERICA, Mass.--(BUSINESS WIRE)-- Bruker Corporation (Nasdaq: BRKR, BRKRP) today announced that its Board of Directors (“Board”) has approved payment of a quarterly cash dividend in the amount of $3.9844 per share on the Company’s 6.375% Mandatory Convertible Preferred Stock, Series A, par value $0.01 per share (the “Mandatory Convertible Preferred Stock Dividend”). The Mandatory Convertible Preferred Stock Dividend will be paid on March 2, 2026 to stockholders of record as of February 15, 2026.

About Bruker Corporation – Leader of the Post-Genomic Era

Bruker is enabling scientists and engineers to make breakthrough post-genomic discoveries and

Bruker Announces Quarterly Preferred Stock Dividend

Thu, 05 Feb 2026 16:05:00 -0500

About Bruker Corporation – Leader of the Post-Genomic Era

Bruker is enabling scientists and engineers to make breakthrough post-genomic discoveries and

Bruker Announces Quarterly Preferred Stock Dividend

Thu, 05 Feb 2026 16:05:00 -0500

About Bruker Corporation – Leader of the Post-Genomic Era

Bruker is enabling scientists and engineers to make breakthrough post-genomic discoveries and

Bruker Announces Quarterly Preferred Stock Dividend

Thu, 05 Feb 2026 16:05:00 -0500

About Bruker Corporation – Leader of the Post-Genomic Era

Bruker is enabling scientists and engineers to make breakthrough post-genomic discoveries and

Bruker Announces Quarterly Preferred Stock Dividend

Thu, 05 Feb 2026 16:05:00 -0500

About Bruker Corporation – Leader of the Post-Genomic Era

Bruker is enabling scientists and engineers to make breakthrough post-genomic discoveries and

Bruker Announces Quarterly Preferred Stock Dividend

Thu, 05 Feb 2026 16:05:00 -0500

About Bruker Corporation – Leader of the Post-Genomic Era

Bruker is enabling scientists and engineers to make breakthrough post-genomic discoveries and

Bruker acquires AST Revolution from Indaba Capital

Mon, 24 Nov 2025 09:00:52 -0500

Bruker Corporation (NASDAQ: BRKR, BRKRP) acquired AST Revolution from Indaba Capital Management, the companies announced. Financial terms of the transaction were not disclosed.

AST Revolution develops rapid antimicrobial susceptibility testing solutions and was formed in August 2025 following Indaba's court-approved acquisition of select assets from Accelerate Diagnostics during its Chapter 11 bankruptcy process. The acquired assets included the WAVE and Arc testing systems and associated intellectual property.

The company focuses on in vitro diagnostics technology designed to provide rapid antimicrobial susceptibility testing results. AST Revolution's WAVE and Arc systems are intended to help clinicians make treatment decisions more quickly.

"The sale of AST

Bruker acquires AST Revolution from Indaba Capital

Mon, 24 Nov 2025 09:00:52 -0500

Bruker Corporation (NASDAQ: BRKR, BRKRP) acquired AST Revolution from Indaba Capital Management, the companies announced. Financial terms of the transaction were not disclosed.

"The sale of AST

Indaba Capital Announces Sale of AST Revolution to Bruker